It is not known if ONUREG® is safe and effective in children under 18 years of age.
BMS Access Support®
Call Bristol Myers Squibb Access Support® at 1-800-861-0048, 8 am to 8 pm ET, Monday-Friday
The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding coverage or reimbursement for any service or item.
Helpful resources for people with AML
Here are some additional links that may provide more resources
Bristol Myers Squibb takes no responsibility for the content of these resources.
Important questions to ask your healthcare team
Always try to talk openly with your healthcare team. Asking questions can help you make informed choices about your care. The following questions are just examples. As your care providers give you answers, consider taking notes, so you can review the information later.
The medical details of AML treatment can seem complex. The following list of definitions may be helpful to you—and to the caregivers, friends, and family who are supporting you.
Acute: An illness that will progress quickly if left untreated
Blasts: Young, immature cells that build up in the bone marrow. They are unable to fight infections the way healthy, mature white blood cells can. Also known as myeloblasts
Bone marrow: The soft interior of the bones where new blood cells are created
Bone marrow transplant: A type of transplant that involves transferring healthy stem cells from a donor to a person with AML. This treatment is also known as a stem cell transplant or a hematopoietic stem cell transplant
Complete remission/remission: The absence of signs and symptoms of AML
Consolidation therapy: Additional chemotherapy treatment that may be given after induction. Consolidation therapy consists of similar drugs used during induction, however, at different doses
Continued treatment: Medication used in a person with AML in first remission, after the first phase of cancer treatment, over an extended period of time
Intensive induction therapy: The first phase of treatment a person with AML receives. This treatment is usually the strongest against blast cells
Neutropenia: A low number of neutrophils (a type of white blood cell)
Placebo: An inactive substance that has no therapeutic effect but may be used to compare the effects of an active drug
Platelets: Help prevent bleeding caused by cuts and bruises (help with blood clotting)
Post-remission treatment: Treatment that is given to continue to keep a person with AML in remission and can help prevent AML from returning
Red blood cells: Carry oxygen from the lungs to all cells in the body
Stem cell transplant: See “Bone marrow transplant”
Thrombocytopenia: A low number of platelets
White blood cells: Help the body fight infections. They are a crucial part of the body’s immune system